Kestra Advisory Services »

Neubase Therapeutics shares owned by Kestra Advisory Services

Quarter-by-quarter ownership of Neubase Therapeutics (NBSE) shares owned by Kestra Advisory Services from 13F filings

Historical chart of Kestra Advisory Services investment in Neubase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neubase Therapeutics held by Kestra Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neubase Therapeutics by Kestra Advisory Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $12k 17k 0.74
2023-09-30 $16k 18k 0.87
2023-06-30 $48k 26k 1.87

More positions owned by Kestra Advisory Services

Apple (AAPL)
Parker-Hannifin Corporation (PH)
Ishares Tr Msci Ac Asia Etf (IVV)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Small Cp Etf (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Small Cp Etf (VTI)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl A (BRK.B)
Vanguard Index Fds Small Cp Etf (VUG)
NVIDIA Corporation (NVDA)
First Tr Exchange-traded Rba Indl Etf (RDVY)
Vanguard Index Fds Small Cp Etf (VTV)
Ishares Tr Msci Ac Asia Etf (IJR)

View all positions for Kestra Advisory Services

Top funds holding Neubase Therapeutics

DME Capital Management
Greenlight Capital
Point72 Asset Management
Carnegie Mellon University
Vanguard Group
Kestra Advisory Services
Springbok Capital Management
Geode Capital Management
UBS Group
Tower Research Capital
Cubist Systematic Strategies
Bank of America Corporation
First Manhattan
Royal Bank of Canada
Wells Fargo & Company

View all funds holding Neubase Therapeutics